Your browser doesn't support javascript.
loading
Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol 2019;76:151-6: Active Surveillance in Metastatic Renal Cell Cancer: Missing a Chance for Cure?
de Joode, Karlijn; van der Veldt, Astrid A M.
Affiliation
  • de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
  • van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl.
Eur Urol ; 77(3): e76-e77, 2020 03.
Article in En | MEDLINE | ID: mdl-31610901
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urology / Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Guideline / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Eur Urol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urology / Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Guideline / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Eur Urol Year: 2020 Document type: Article Affiliation country: Country of publication: